Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 275-277
◽
Keyword(s):
2009 ◽
Vol 137
(6)
◽
pp. 2002-2009
◽
2018 ◽
Vol 117
(7)
◽
pp. 588-597
◽
2011 ◽
Vol 34
(4)
◽
pp. 424-431
◽